Literature DB >> 24728220

[Cutaneous drug reactions imitating dermatoses].

N Magnolo1, T Schwarz, S Ständer.   

Abstract

BACKGROUND: Cutaneous adverse drug reactions are frequent and present with heterogenous clinical manifestations. METHODS AND
RESULTS: Increasingly, case reports describe drug reactions which mimic dermatoses, although exact data on prevalence are missing. Psoriasiform, lichenoid and pityriasiform exanthems are most frequent. The differentiation of these variants from the respective authentic dermatoses is difficult and only a few clinical and histological criteria are helpful. Other dermatoses like lupus erythematosus or bullous autoimmune dermatoses (pemphigus vulgaris, bullous pemphigoid) can be induced by drugs as well. These drug-triggered variations are classified as distinct subclasses of the respective dermatosis.
CONCLUSIONS: Exact history and evaluation of the clinical course are essential for the diagnosis of drug reactions mimicking dermatoses and present an important challenge for the clinician. A clear-cut differentiation between the genuine dermatosis and its drug-driven simulator is not always possible.

Entities:  

Mesh:

Year:  2014        PMID: 24728220     DOI: 10.1007/s00105-013-2697-8

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  29 in total

1.  A psoriasiform drug eruption induced by polyethylene glycol interferon-alpha-2b, successfully treated by narrow band ultraviolet B therapy.

Authors:  Shinji Kuwabara; Hideki Maejima; Akira Watarai; Yuko Hamada; Kensei Katsuoka
Journal:  Eur J Dermatol       Date:  2012 Jan-Feb       Impact factor: 3.328

Review 2.  Autoimmune bullous skin diseases. Part 1: Clinical manifestations.

Authors:  Andrea Kneisel; Michael Hertl
Journal:  J Dtsch Dermatol Ges       Date:  2011-10       Impact factor: 5.584

3.  Lichen planus under anti TNF therapy for ankylosing spondylitis.

Authors:  Daniel Wendling; Caroline Biver-Dalle; Claire Vidon; Clément Prati; François Aubin
Journal:  Joint Bone Spine       Date:  2013-03-01       Impact factor: 4.929

4.  Drug-induced pemphigus.

Authors:  Sarah Brenner; Ilan Goldberg
Journal:  Clin Dermatol       Date:  2011 Jul-Aug       Impact factor: 3.541

5.  Adverse cutaneous drug reactions among hospitalized patients: five year surveillance.

Authors:  Bengu Gerceker Turk; Asli Gunaydin; Ilgen Ertam; Gunseli Ozturk
Journal:  Cutan Ocul Toxicol       Date:  2012-07-20       Impact factor: 1.820

6.  Cutaneous drug eruptions associated with the use of biologies and cutaneous drug eruptions mimicking specific skin diseases.

Authors:  Julien Seneschal; Brigitte Milpied; Alain Taieb
Journal:  Chem Immunol Allergy       Date:  2012-05-03

7.  Immunostaining with antibodies to desmoglein provides the diagnosis of drug-induced pemphigus and allows prediction of outcome.

Authors:  Annabel Maruani; Marie-Christine Machet; Agnès Carlotti; Bruno Giraudeau; Loïc Vaillant; Laurent Machet
Journal:  Am J Clin Pathol       Date:  2008-09       Impact factor: 2.493

8.  Cutaneous lupus erythematosus: first multicenter database analysis of 1002 patients from the European Society of Cutaneous Lupus Erythematosus (EUSCLE).

Authors:  Cyrus Biazar; Johanna Sigges; Nikolaos Patsinakidis; Vincent Ruland; Susanne Amler; Gisela Bonsmann; Annegret Kuhn
Journal:  Autoimmun Rev       Date:  2012-09-18       Impact factor: 9.754

9.  Transition of psoriasiform drug eruption to psoriasis de novo evidenced by histopathology.

Authors:  Mayuko Yamamoto; Mitsunori Ikeda; Hajime Kodama; Shigetoshi Sano
Journal:  J Dermatol       Date:  2008-11       Impact factor: 4.005

Review 10.  Drug-induced lupus erythematosus with emphasis on skin manifestations and the role of anti-TNFα agents.

Authors:  Camilla Dalle Vedove; Jan C Simon; Giampiero Girolomoni
Journal:  J Dtsch Dermatol Ges       Date:  2012-09-03       Impact factor: 5.584

View more
  1 in total

1.  Eczema-Like Psoriasiform Skin Reaction due to Brazilian Keratin Treatment.

Authors:  Maria Fernanda Reis Gavazzoni-Dias; Mayra Rochael; Enoï Vilar; Aline Tanus; Antonella Tosti
Journal:  Skin Appendage Disord       Date:  2016-01-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.